These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12100017)

  • 21. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K; Bentsman G; Chess L; Volsky DJ
    J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of immunity in protection from mucosal SIV infection in macaques.
    Bergmeier LA; Wang Y; Lehner T
    Oral Dis; 2002; 8 Suppl 2():63-8. PubMed ID: 12164663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine.
    Putkonen P; Walther L; Zhang YJ; Li SL; Nilsson C; Albert J; Biberfeld P; Thorstensson R; Biberfeld G
    Nat Med; 1995 Sep; 1(9):914-8. PubMed ID: 7585217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A decline in CCL3-5 chemokine gene expression during primary simian-human immunodeficiency virus infection.
    Zhao W; Pahar B; Borda JT; Alvarez X; Sestak K
    PLoS One; 2007 Aug; 2(8):e726. PubMed ID: 17684570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.
    Lehner T; Wang Y; Cranage M; Tao L; Mitchell E; Bravery C; Doyle C; Pratt K; Hall G; Dennis M; Villinger L; Bergmeier L
    Immunology; 2000 Apr; 99(4):569-77. PubMed ID: 10792505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative investigation of CC chemokines and SIV suppressor factors generated by CD8+ and CD4+ T cells and CD14+ monocytes.
    Babaahmady K; Bergmeier LA; Whittall T; Singh M; Wang Y; Lehner T
    J Immunol Methods; 2002 Jun; 264(1-2):1-10. PubMed ID: 12191503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
    Putkonen P; Thorstensson R; Albert J; Hild K; Norrby E; Biberfeld P; Biberfeld G
    AIDS; 1990 Aug; 4(8):783-9. PubMed ID: 1979745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytes.
    Sun Y; Schmitz JE; Acierno PM; Santra S; Subbramanian RA; Barouch DH; Gorgone DA; Lifton MA; Beaudry KR; Manson K; Philippon V; Xu L; Maecker HT; Mascola JR; Panicali D; Nabel GJ; Letvin NL
    J Immunol; 2005 Apr; 174(8):4753-60. PubMed ID: 15814700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
    De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RANTES, IFN-gamma, CCR1, and CCR5 mRNA expression in peripheral blood, lymph node, and bronchoalveolar lavage mononuclear cells during primary simian immunodeficiency virus infection of macaques.
    Chéret A; Le Grand R; Caufour P; Neildez O; Matheux F; Théodoro F; Vaslin B; Dormont D
    Virology; 1999 Mar; 255(2):285-93. PubMed ID: 10069954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.
    Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F
    Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.
    Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M
    J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of immune response in macaque monkeys infected with simian-human immunodeficiency virus having the TNF-alpha gene at an early stage of infection.
    Shimizu Y; Miyazaki Y; Ibuki K; Suzuki H; Kaneyasu K; Goto Y; Hayami M; Miura T; Haga T
    Virology; 2005 Dec; 343(2):151-61. PubMed ID: 16169034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates.
    Waterman PM; Kitabwalla M; Hatfield GS; Evans PS; Lu Y; Tikhonov I; Bryant JL; Pauza CD
    Viral Immunol; 2004; 17(4):545-57. PubMed ID: 15671751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection.
    Bogers WM; Bergmeier LA; Ma J; Oostermeijer H; Wang Y; Kelly CG; Ten Haaft P; Singh M; Heeney JL; Lehner T
    AIDS; 2004 Jan; 18(1):25-36. PubMed ID: 15090826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-gamma.
    Iida T; Kuwata T; Ui M; Suzuki H; Miura T; Ibuki K; Takahashi H; Yamamoto T; Imanishi J; Hayami M; Kita M
    Arch Virol; 2004 Apr; 149(4):743-57. PubMed ID: 15045561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
    Busch M; Abel K; Li J; Piatak M; Lifson JD; Miller CJ
    Vaccine; 2005 Jul; 23(31):4036-47. PubMed ID: 15963361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.
    Greco G; Fujimura SH; Mourich DV; Levy JA
    J Virol; 1999 Feb; 73(2):1528-34. PubMed ID: 9882358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.